KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Cash from Financing Activities (2020 - 2025)

AbCellera Biologics' Cash from Financing Activities history spans 6 years, with the latest figure at $4.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 0.65% year-over-year to $4.1 million, compared with a TTM value of $14.1 million through Dec 2025, up 10.28%, and an annual FY2025 reading of $14.1 million, up 10.28% over the prior year.
  • Cash from Financing Activities for Q4 2025 was $4.1 million at AbCellera Biologics, down from $7.4 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $7.4 million in Q3 2025, with the low at -$5.1 million in Q2 2021.
  • Average Cash from Financing Activities over 5 years is $1.6 million, with a median of $1.5 million recorded in 2021.
  • Year-over-year, Cash from Financing Activities tumbled 1566.76% in 2021 and then skyrocketed 34994.74% in 2023.
  • Tracing ABCL's Cash from Financing Activities over 5 years: stood at $1.8 million in 2021, then crashed by 80.97% to $349000.0 in 2022, then skyrocketed by 978.8% to $3.8 million in 2023, then rose by 10.01% to $4.1 million in 2024, then fell by 0.65% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Cash from Financing Activities are $4.1 million (Q4 2025), $7.4 million (Q3 2025), and -$3.4 million (Q2 2025).